Category: Pharmaceuticals
Sandoz Erelzi™ (etanercept) Receives Positive Reimbursement Recommendation from Common Drug Review for Treatment of Multiple Inflammatory Diseases
Sandoz, a Novartis division, recently announced that The Canadian Drug Expert Committee (CDEC) as part of the Common Drug Review (CDR) process has issued a positive drug reimbursement recommendation f... Read More- 3 of 3
- « Previous
- 1
- 2
- 3

